People carrying at least one APOE4 allele have a higher risk of Alzheimer's disease compared with APOE3/3 carriers; people with two APOE4 alleles have the highest risk. The APOE2 allele is associated ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they consumed relatively large amounts of meat.

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Guest columnist Melissa Zapanta Shelton is executive director of the Alzheimer’s Association Cleveland and Greater East Ohio chapters. Currently, 55 million people are living with Alzheimer’s disease ...

New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than ...

The findings could help clinicians use neuropsychiatric symptoms to prepare patients and families for a type of dementia ...

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

Research roundtable highlights early detection, biomarkers, interventions ...

Free educational event brings together clinical experts, resources, and community support for those navigating memory ...

Have you ever wondered how an Alzheimer’s patient literally views the world and what they experience in the confusion? Now, families and caregivers can have the experience through special goggles ...